INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 116 filers reported holding INHIBRX INC in Q4 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,519 | -26.7% | 17,140 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $429,119 | +44.6% | 16,530 | +5.1% | 0.00% | +50.0% |
| Q1 2023 | $296,712 | -21.9% | 15,724 | +2.0% | 0.00% | -33.3% |
| Q4 2022 | $379,727 | +52.5% | 15,411 | +11.2% | 0.00% | +50.0% |
| Q3 2022 | $249,000 | +60.6% | 13,859 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $155,000 | -49.8% | 13,664 | -1.4% | 0.00% | -50.0% |
| Q1 2022 | $309,000 | -52.3% | 13,859 | -6.6% | 0.00% | -33.3% |
| Q4 2021 | $648,000 | +27.3% | 14,835 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $509,000 | +18.4% | 15,278 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $430,000 | +352.6% | 15,642 | +230.2% | 0.00% | – |
| Q1 2021 | $95,000 | -39.1% | 4,737 | +0.3% | 0.00% | -100.0% |
| Q4 2020 | $156,000 | – | 4,725 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |